On October 28, 2024, Subun Pharmaceuticals stock price rose 3.28% to close at Rs 1,287.85, just 1.23% off its 52-week high. According to MarketsMojo, the current call on Sven Pharmaceuticals’ stock is “Hold”, outperforming the sector by 2.09%. The stock price also had a volatile trading day, but is currently trading above its moving average. Get detailed stock report
Suven Pharmaceuticals, a leading company in the pharmaceutical and pharmaceutical industry, is showing positive trends in its stock price performance on October 28, 2024. The company’s shares rose 3.28% to close at Rs 1,287.85. This is just 1.23% off its 52-week high of Rs 1,307.95.
According to MarketsMOJO, a leading stock market analysis platform, the current call on Sven Pharmaceuticals’ stock is “Hold.” On the same day, it outperformed the sector by 2.09%.
During the day, the stock rose 3.28% to an intraday high of Rs 1,292.05 and fell 2.13% to an intraday low of Rs 1,224.3. This indicates a volatile trading day for a company’s stock.
Sven Pharmaceuticals is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the company’s stock price performance.
In comparison to the overall market performance, Subun Pharmaceuticals outperformed the Sensex by 2.27% over the past day and by 10.57% over the past month. This shows the company’s stock is performing well despite the overall negative trend in the market.
Overall, Subun Pharmaceuticals is showing a positive trend in stock price performance on October 28, 2024, and is currently trading above its moving average. Investors may want to keep an eye on the company’s stock for its future growth potential.
